NIH launches clinical trial of Epstein-Barr virus vaccine
The vaccine works by targetting EBV glycoprotein gp350, which is found on the surface of the virus and virus-infected cells
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.